![](https://endpts.com/wp-content/uploads/2022/02/Craig-Tooman-Silence-tile-scaled.jpg)
Craig Tooman, Silence Therapeutics CEO
Silence reports positive PhII cholesterol drug data, reveals end to Mallinckrodt alliance
Silence Therapeutics has reported its siRNA drug candidate showed positive results in a mid-stage test of patients with high low-density lipoprotein at risk of cardiovascular …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.